Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 5

1.

Parkin dosage mutations have greater pathogenicity in familial PD than simple sequence mutations.

Pankratz N, Kissell DK, Pauciulo MW, Halter CA, Rudolph A, Pfeiffer RF, Marder KS, Foroud T, Nichols WC; Parkinson Study Group-PROGENI Investigators.

Neurology. 2009 Jul 28;73(4):279-86. doi: 10.1212/WNL.0b013e3181af7a33.

2.

Distribution, type, and origin of Parkin mutations: review and case studies.

Hedrich K, Eskelson C, Wilmot B, Marder K, Harris J, Garrels J, Meija-Santana H, Vieregge P, Jacobs H, Bressman SB, Lang AE, Kann M, Abbruzzese G, Martinelli P, Schwinger E, Ozelius LJ, Pramstaller PP, Klein C, Kramer P.

Mov Disord. 2004 Oct;19(10):1146-57. Review.

PMID:
15390068
3.

[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].

Hattori N.

Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Review. Japanese.

PMID:
15287506
4.

Genetics of parkin-linked disease.

West AB, Maidment NT.

Hum Genet. 2004 Mar;114(4):327-36. Epub 2004 Jan 15. Review.

PMID:
14727181
5.

Functional parkin promoter polymorphism in Parkinson's disease: new data and meta-analysis.

Chang XL, Mao XY, Li HH, Zhang JH, Li NN, Burgunder JM, Peng R, Tan EK.

J Neurol Sci. 2011 Mar 15;302(1-2):68-71. doi: 10.1016/j.jns.2010.11.023. Epub 2010 Dec 21. Review.

PMID:
21176923

Supplemental Content

Support Center